| 1 |
30474276 | Gelatin nonwovens-based epithelial morphogenesis involves a signaling axis comprising EGF-receptor, MAP kinases ERK 1/2, and β1 integrin. | 2019 Mar |
1 |
| 2 |
31454111 | Epiregulin enhances odontoblastic differentiation of dental pulp stem cells via activating MAPK signalling pathway. | 2019 Nov |
1 |
| 3 |
29215723 | High cholesterol in lipid rafts reduces the sensitivity to EGFR-TKI therapy in non-small cell lung cancer. | 2018 Sep |
1 |
| 4 |
29480364 | Combination of S-1 and gefitinib increases the sensitivity to radiotherapy in lung cancer cells. | 2018 Apr |
1 |
| 5 |
29517107 | FGFR inhibitor AZD4547 can enhance sensitivity of esophageal squamous cell carcinoma cells with epithelial‑mesenchymal transition to gefitinib. | 2018 May |
1 |
| 6 |
29383165 | Gefitinib enhances sensitivity of endometrial cancer cells to progestin therapy via dual-specificity phosphatase 1. | 2017 Dec 29 |
1 |
| 7 |
27716616 | Ran GTPase promotes cancer progression via Met recepto-rmediated downstream signaling. | 2016 Nov 15 |
1 |
| 8 |
25662161 | Down-regulation of ERK1/2 and AKT-mediated X-ray repair cross-complement group 1 protein (XRCC1) expression by Hsp90 inhibition enhances the gefitinib-induced cytotoxicity in human lung cancer cells. | 2015 May 15 |
5 |
| 9 |
25879333 | The effects of combination of gefitinib and cisplatin on tongue squamous cell carcinoma cell lines. | 2015 Jan-Mar |
1 |
| 10 |
26176330 | The small GTPase ADP-Ribosylation Factor 1 mediates the sensitivity of triple negative breast cancer cells to EGFR tyrosine kinase inhibitors. | 2015 |
1 |
| 11 |
26517520 | 244-MPT overcomes gefitinib resistance in non-small cell lung cancer cells. | 2015 Dec 29 |
1 |
| 12 |
24884778 | Enhancement of gefitinib-induced growth inhibition by Marsdenia tenacissima extract in non-small cell lung cancer cells expressing wild or mutant EGFR. | 2014 May 22 |
2 |
| 13 |
23533381 | Combined Effects of PPAR γ Agonists and Epidermal Growth Factor Receptor Inhibitors in Human Proximal Tubule Cells. | 2013 |
1 |
| 14 |
24034993 | [c-Met signaling pathway participating in the gefitinib resistance of different gene types of non-small cell lung cancer cells induced by HGF in vitro]. | 2013 Sep |
1 |
| 15 |
24146879 | Induction of autophagy is an early response to gefitinib and a potential therapeutic target in breast cancer. | 2013 |
1 |
| 16 |
21544845 | Regulation of cigarette smoke-mediated mucin expression by hypoxia-inducible factor-1α via epidermal growth factor receptor-mediated signaling pathways. | 2012 Apr |
3 |
| 17 |
21787763 | Receptor tyrosine kinase inhibitors and cytotoxic drugs affect pleural mesothelioma cell proliferation: insight into EGFR and ERK1/2 as antitumor targets. | 2011 Nov 15 |
2 |
| 18 |
19760159 | Lovastatin overcomes gefitinib resistance in human non-small cell lung cancer cells with K-Ras mutations. | 2010 Dec |
1 |
| 19 |
19922467 | EGF receptor in relation to tumor development: molecular basis of responsiveness of cancer cells to EGFR-targeting tyrosine kinase inhibitors. | 2010 Jan |
1 |
| 20 |
20088784 | Gefitinib targets EGFR dimerization and ERK1/2 phosphorylation to inhibit pleural mesothelioma cell proliferation. | 2010 Mar |
2 |
| 21 |
19147502 | Different response of human glioma tumor-initiating cells to epidermal growth factor receptor kinase inhibitors. | 2009 Mar 13 |
1 |
| 22 |
19157634 | The role of celecoxib in Rad51 expression and cell survival affected by gefitinib in human non-small cell lung cancer cells. | 2009 Sep |
2 |
| 23 |
19233551 | Bisphosphonate zoledronic acid enhances the inhibitory effects of gefitinib on EGFR-mutated non-small cell lung carcinoma cells. | 2009 Jun 8 |
1 |
| 24 |
19318490 | Proteomic signatures of epidermal growth factor receptor and survival signal pathways correspond to gefitinib sensitivity in head and neck cancer. | 2009 Apr 1 |
1 |
| 25 |
19380191 | Epidermal growth factor competes with EGF receptor inhibitors to induce cell death in EGFR-overexpressing tumor cells. | 2009 Oct 8 |
1 |
| 26 |
19505457 | Emodin enhances gefitinib-induced cytotoxicity via Rad51 downregulation and ERK1/2 inactivation. | 2009 Sep 10 |
2 |
| 27 |
17959712 | 17beta-estradiol promotes breast cancer cell proliferation-inducing stromal cell-derived factor-1-mediated epidermal growth factor receptor transactivation: reversal by gefitinib pretreatment. | 2008 Jan |
1 |
| 28 |
18292095 | Epidermal growth factor plays a crucial role in mitogenic regulation of human brain tumor stem cells. | 2008 Apr 18 |
1 |
| 29 |
18347153 | Modulation of survival pathways in ovarian carcinoma cell lines resistant to platinum compounds. | 2008 Mar |
1 |
| 30 |
18377894 | The role of repair protein Rad51 in synergistic cytotoxicity and mutagenicity induced by epidermal growth factor receptor inhibitor (Gefitinib, IressaR) and benzo[a]pyrene in human lung cancer. | 2008 May 1 |
5 |
| 31 |
18544565 | Involvement of Rad51 in cytotoxicity induced by epidermal growth factor receptor inhibitor (gefitinib, IressaR) and chemotherapeutic agents in human lung cancer cells. | 2008 Jul |
6 |
| 32 |
18980991 | Autocrine production of amphiregulin predicts sensitivity to both gefitinib and cetuximab in EGFR wild-type cancers. | 2008 Nov 1 |
1 |
| 33 |
19001445 | Role of repair protein Rad51 in regulating the response to gefitinib in human non-small cell lung cancer cells. | 2008 Nov |
4 |
| 34 |
17270025 | Activation of downstream epidermal growth factor receptor (EGFR) signaling provides gefitinib-resistance in cells carrying EGFR mutation. | 2007 Mar |
1 |
| 35 |
17409805 | The effect of gefitinib on B-RAF mutant non-small cell lung cancer and transfectants. | 2007 Apr |
1 |
| 36 |
17686159 | Heregulin beta1 drives gefitinib-resistant growth and invasion in tamoxifen-resistant MCF-7 breast cancer cells. | 2007 |
2 |
| 37 |
17699786 | Emergence of epidermal growth factor receptor T790M mutation during chronic exposure to gefitinib in a non small cell lung cancer cell line. | 2007 Aug 15 |
1 |
| 38 |
16261397 | Bidirectional cross talk between ERalpha and EGFR signalling pathways regulates tamoxifen-resistant growth. | 2006 Mar |
1 |
| 39 |
16568376 | Gefitinib and the modulation of the signaling pathways downstream of epidermal growth factor receptor in human liver cancer cells. | 2006 Feb |
2 |
| 40 |
16937523 | Prolonged exposure of colon cancer cells to the epidermal growth factor receptor inhibitor gefitinib (Iressa(TM)) and to the antiangiogenic agent ZD6474: Cytotoxic and biomolecular effects. | 2006 Aug 28 |
1 |
| 41 |
16106023 | Differential effects of gefitinib and cetuximab on non-small-cell lung cancers bearing epidermal growth factor receptor mutations. | 2005 Aug 17 |
1 |
| 42 |
15078990 | Sensitivity to gefitinib (Iressa, ZD1839) in non-small cell lung cancer cell lines correlates with dependence on the epidermal growth factor (EGF) receptor/extracellular signal-regulated kinase 1/2 and EGF receptor/Akt pathway for proliferation. | 2004 Apr |
2 |
| 43 |
15582135 | Targeting the epidermal growth factor receptor by gefitinib for treatment of hepatocellular carcinoma. | 2004 Dec |
1 |
| 44 |
12234991 | Inhibition of epidermal growth factor receptor signaling in malignant pleural mesothelioma. | 2002 Sep 15 |
1 |